Company Filing History:
Years Active: 2009-2017
Title: The Innovations of Inventor Stephen McCraith
Introduction
Stephen McCraith is an accomplished inventor based in Seattle, WA, known for his significant contributions to the field of pharmaceuticals. With a portfolio of 3 patents, McCraith has developed innovative solutions aimed at targeting cancer cells and modifying therapeutic molecules.
Latest Patents
Among his latest patents, McCraith has created pharmaceutical compounds that utilize affinity-tethered moieties targeted by macrophage migration inhibitory factor (MIF). This groundbreaking work involves a compound, a pharmaceutical composition, and a method of treatment that utilizes a tethering moiety binding to MIF polypeptide. By linking a drug moiety or imaging agent to this tethering moiety, his invention enables targeted delivery to cancer or immune cells, enhancing therapeutic efficacy.
Another significant patent by McCraith involves modified human interferon-beta polypeptides. This invention provides methods for identifying, modifying, and producing therapeutic molecules by the strategic modification with non-natural amino acids. It includes a novel approach for adding chemical moieties to target molecules, as well as kits designed for the efficient identification and modification of these molecules.
Career Highlights
Throughout his career, Stephen McCraith has worked with several prestigious companies, including Allozyne, Inc. and RJS Biologics. His experience in these organizations has significantly contributed to his expertise in the development of innovative pharmaceutical solutions and therapeutic technologies.
Collaborations
McCraith has had the opportunity to collaborate with notable professionals in his field, such as Kenneth H. Grabstein and Natalie Winblade Nairn. These collaborations have further enriched his work and bolstered the development of the innovative compounds that he has patented.
Conclusion
Stephen McCraith stands out as a noteworthy inventor whose patents reflect his dedication to advancing pharmaceutical science. His latest inventions, aimed at improving targeted therapies for cancer, underscore his commitment to innovation in the medical field. As he continues his work, McCraith's contributions will undoubtedly play an essential role in healthcare advancements.